Surgical management of brainstem hemangioblastomas in patients with von Hippel—Lindau disease

View More View Less
  • 1 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object. Hemangioblastomas of the brainstem constitute 5 to 10% of central nervous system (CNS) tumors in patients with von Hippel—Lindau (VHL) disease. At present, optimal management of brainstem hemangioblastomas associated with VHL disease is incompletely defined. In an attempt to clarify some of the uncertainty about the operative treatment of these lesions and its outcome, the authors reviewed all cases of VHL disease in which resection of brainstem hemangioblastomas was performed at the National Institutes of Health during a 10-year period.

Methods. Twelve consecutive patients with VHL disease (six male and six female patients [mean age 31.7 ± 9 years; range 15–46 years]) who underwent 13 operations to remove 17 brainstem hemangioblastomas were included in this study (mean follow-up period, 88.4 ± 37.4 months; range 37–144 months). Serial examinations, hospital charts, magnetic resonance images, and operative records were reviewed. To evaluate clinical course, clinical grades were assigned to each patient before and after surgery.

Preoperative neurological function was the best predictor of long-term outcome. In addition, patients who underwent CNS surgeries for hemangioblastomas were more likely to improve or to remain neurologically stable. Tumor or cyst size, the presence of a cyst, or the location of the tumor (intramedullary, extramedullary, or mixed; posterior medullary, obex, or lateral) did not affect outcome. No patient was neurologically worse after brainstem surgery. At long-term follow-up review (mean 88.4 months), only one patient had declined neurologically and this was due to the cumulative neurological effects caused by eight additional hemangioblastomas of the spinal cord and their surgical treatment.

Conclusions. Brainstem hemangioblastomas in patients with VHL disease can be removed safely; they generally should be resected when they become symptomatic or when the tumor has reached a size such that further growth will increase the risks associated with surgery, or in the presence of an enlarging cyst. Magnetic resonance imaging is usually sufficient for preoperative evaluation and presurgical embolization is unnecessary. The goal of surgery is complete resection of the lesion before the patient experiences a disabling neurological deficit.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Robert J. Weil, M.D., Surgical Neurology Branch, NINDS, NIH, Building 10, Room 5D 37, Bethesda, Maryland 20892–1414. email: weilr@ninds.nih.gov.
  • 1.

    Ahyai A, , Woerner U, & Markakis E: Surgical treatment of intramedullary tumors (spinal cord and medulla oblongata). Analysis of 16 cases. Neurosurg Rev 13:4552, 1990 Ahyai A, Woerner U, Markakis E: Surgical treatment of intramedullary tumors (spinal cord and medulla oblongata). Analysis of 16 cases. Neurosurg Rev 13:45–52, 1990

    • Search Google Scholar
    • Export Citation
  • 2.

    Baumgartner JE, & Wilson CB: Removal of posterior fossa and spinal hemangioblastomas, in CB Wilson (ed): Neurosurgical Procedures: Personal Approaches to Classic Operations. Baltimore: Williams & Wilkins, 1992, pp 188199 Baumgartner JE, Wilson CB: Removal of posterior fossa and spinal hemangioblastomas, in CB Wilson (ed): Neurosurgical Procedures: Personal Approaches to Classic Operations. Baltimore: Williams & Wilkins, 1992, pp 188–199

    • Search Google Scholar
    • Export Citation
  • 3.

    Brauch H, , Kishida T, & Glavac D, et al: Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet 95:551556, 1995 Brauch H, Kishida T, Glavac D, et al: Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet 95:551–556, 1995

    • Search Google Scholar
    • Export Citation
  • 4.

    Chang SD, , Meisel JA, & Hancock SL, et al: Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:2835, 1998 Chang SD, Meisel JA, Hancock SL, et al: Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28–35, 1998

    • Search Google Scholar
    • Export Citation
  • 5.

    Chen F, , Kishida T, & Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:6675, 1995 Chen F, Kishida T, Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66–75, 1995

    • Search Google Scholar
    • Export Citation
  • 6.

    Chen F, , Slife L, & Kishida T, et al: Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. J Med Genet 33:716717, 1996 Chen F, Slife L, Kishida T, et al: Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. J Med Genet 33:716–717, 1996

    • Search Google Scholar
    • Export Citation
  • 7.

    Chou SN, , Erickson DL, & Oritiz-Suarez HJ: Surgical treatment of vascular lesions in the brain stem. J Neurosurg 42:2331, 1975 Chou SN, Erickson DL, Oritiz-Suarez HJ: Surgical treatment of vascular lesions in the brain stem. J Neurosurg 42:23–31, 1975

    • Search Google Scholar
    • Export Citation
  • 8.

    Collins ET: Intra-ocular growths. Two cases, brother and sister, with peculiar vascular new growth, probably primarily retinal, affecting both eyes. Trans Ophthalmol Soc UK 14:141149, 1894 (Reference unverified) Collins ET: Intra-ocular growths. Two cases, brother and sister, with peculiar vascular new growth, probably primarily retinal, affecting both eyes. Trans Ophthalmol Soc UK 14:141–149, 1894 (Reference unverified)

    • Search Google Scholar
    • Export Citation
  • 9.

    Constans JP, , Meder F, & Maiuri F, et al: Posterior fossa hemangioblastomas. Surg Neurol 25:269275, 1986 Constans JP, Meder F, Maiuri F, et al: Posterior fossa hemangioblastomas. Surg Neurol 25:269–275, 1986

    • Search Google Scholar
    • Export Citation
  • 10.

    Conway JE, , Chou D, & Clatterbuck RE, et al: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:5563, 2001 Conway JE, Chou D, Clatterbuck RE, et al: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55–63, 2001

    • Search Google Scholar
    • Export Citation
  • 11.

    Crossey PA, , Foster K, & Richards FM, et al: Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 93:5358, 1994 Crossey PA, Foster K, Richards FM, et al: Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 93:53–58, 1994

    • Search Google Scholar
    • Export Citation
  • 12.

    Cushing H, & Bailey P: Hemangiomas of cerebellum and retina (Lindau's disease). With the report of a case. Arch Ophthalmol 57:447463, 1928 Cushing H, Bailey P: Hemangiomas of cerebellum and retina (Lindau's disease). With the report of a case. Arch Ophthalmol 57:447–463, 1928

    • Search Google Scholar
    • Export Citation
  • 13.

    Djindjian M: Successful removal of a brainstem hemangioblastoma. Surg Neurol 25:97100, 1986 Djindjian M: Successful removal of a brainstem hemangioblastoma. Surg Neurol 25:97–100, 1986

    • Search Google Scholar
    • Export Citation
  • 14.

    Duan DR, , Humphrey JS, & Chen DYT, et al: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92:64596463, 1995 Duan DR, Humphrey JS, Chen DYT, et al: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92:6459–6463, 1995

    • Search Google Scholar
    • Export Citation
  • 15.

    Duan DR, , Pause A, & Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:14021406, 1995 Duan DR, Pause A, Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402–1406, 1995

    • Search Google Scholar
    • Export Citation
  • 16.

    Filling-Katz MR, , Choyke PL, & Oldfield E, et al: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:4146, 1991 Filling-Katz MR, Choyke PL, Oldfield E, et al: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41–46, 1991

    • Search Google Scholar
    • Export Citation
  • 17.

    Glenn GM, , Linehan WM, & Hosoe S, et al: Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 267:12261231, 1992 Glenn GM, Linehan WM, Hosoe S, et al: Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 267:1226–1231, 1992

    • Search Google Scholar
    • Export Citation
  • 18.

    Hosoe S, , Brauch H, & Latif F, et al: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634640, 1990 Hosoe S, Brauch H, Latif F, et al: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634–640, 1990

    • Search Google Scholar
    • Export Citation
  • 19.

    Iliopoulos O, , Kibel A, & Gray S, et al: Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1:822826, 1995 Iliopoulos O, Kibel A, Gray S, et al: Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1:822–826, 1995

    • Search Google Scholar
    • Export Citation
  • 20.

    Jackson H: A series of cases illustrative of cerebral pathology. I—Cerebral tumors. Med Times Hosp Gaz (London) 2:541568, 1872 (Reference unverified) Jackson H: A series of cases illustrative of cerebral pathology. I—Cerebral tumors. Med Times Hosp Gaz (London) 2:541–568, 1872 (Reference unverified)

    • Search Google Scholar
    • Export Citation
  • 21.

    Kanno H, , Kondo K, & Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:48454847, 1994 Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845–4847, 1994

    • Search Google Scholar
    • Export Citation
  • 22.

    Kishida T, , Stackhouse TM, & Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:45444548, 1995 Kishida T, Stackhouse TM, Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544–4548, 1995

    • Search Google Scholar
    • Export Citation
  • 23.

    Kohno K, , Matsui S, & Nishizaki A, et al: Successful total removal of intramedullary hemangioblastoma from the medulla oblongata. Surg Neurol 39:2530, 1993 Kohno K, Matsui S, Nishizaki A, et al: Successful total removal of intramedullary hemangioblastoma from the medulla oblongata. Surg Neurol 39:25–30, 1993

    • Search Google Scholar
    • Export Citation
  • 24.

    Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:14371443, 1985 Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437–1443, 1985

    • Search Google Scholar
    • Export Citation
  • 25.

    Latif F, , Tory K, & Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:13171320, 1993 Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320, 1993

    • Search Google Scholar
    • Export Citation
  • 26.

    Lindau A: Studien über Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand Supp 1:1128, 1926 Lindau A: Studien über Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand Supp 1:1–128, 1926

    • Search Google Scholar
    • Export Citation
  • 27.

    Lindau A: Zur Frage der Angiomatosis retinae und ihrer Hirnkomplikationen. Acta Ophthalmol 4:193226, 1927 Lindau A: Zur Frage der Angiomatosis retinae und ihrer Hirnkomplikationen. Acta Ophthalmol 4:193–226, 1927

    • Search Google Scholar
    • Export Citation
  • 28.

    Lonser RR, , Weil RJ, & Wanebo, JE, et al: Surgical management of spinal cord hemangioblastomas in patients with von Hippel—Lindau disease. J Neurosurg 98:106116, 2003 Lonser RR, Weil RJ, Wanebo, JE, et al: Surgical management of spinal cord hemangioblastomas in patients with von Hippel—Lindau disease. J Neurosurg 98:106–116, 2003

    • Search Google Scholar
    • Export Citation
  • 29.

    Lundin P, & Pedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:519528, 1992 Lundin P, Pedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:519–528, 1992

    • Search Google Scholar
    • Export Citation
  • 30.

    Maher ER, , Webster AR, & Moore AT: Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:7984, 1995 Maher ER, Webster AR, Moore AT: Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79–84, 1995

    • Search Google Scholar
    • Export Citation
  • 31.

    Maher ER, , Yates JRW, & Harries R, et al: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:11511163, 1990 Maher ER, Yates JRW, Harries R, et al: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163, 1990

    • Search Google Scholar
    • Export Citation
  • 32.

    Manski TJ, , Heffner DK, & Glenn GM, et al: Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:14611466, 1997 Manski TJ, Heffner DK, Glenn GM, et al: Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466, 1997

    • Search Google Scholar
    • Export Citation
  • 33.

    McCormick PC, , Torres R, & Post KD, et al: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523532, 1990 McCormick PC, Torres R, Post KD, et al: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523–532, 1990

    • Search Google Scholar
    • Export Citation
  • 34.

    Melmon KL, & Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595617, 1964 Melmon KL, Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595–617, 1964

    • Search Google Scholar
    • Export Citation
  • 35.

    Neumann HP, , Eggert HR, & Scheremet R, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898901, 1992 Neumann HP, Eggert HR, Scheremet R, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898–901, 1992

    • Search Google Scholar
    • Export Citation
  • 36.

    Neumann HP, , Eggert HR, & Weigel K, et al: Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:2430, 1989 Neumann HP, Eggert HR, Weigel K, et al: Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24–30, 1989

    • Search Google Scholar
    • Export Citation
  • 37.

    Niemela M, , Lim YJ, & Soderman M, et al: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591596, 1996 Niemela M, Lim YJ, Soderman M, et al: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591–596, 1996

    • Search Google Scholar
    • Export Citation
  • 38.

    Nishimoto A, & Kawakami Y: Surgical removal of hemangioblastoma in the fourth ventricle. Surg Neurol 13:423427, 1980 Nishimoto A, Kawakami Y: Surgical removal of hemangioblastoma in the fourth ventricle. Surg Neurol 13:423–427, 1980

    • Search Google Scholar
    • Export Citation
  • 39.

    Rawe SE, , Van Gilder JC, & Rothman SLG: Radiographic diagnostic evaluation and surgical treatment of multiple cerebellar, brain stem, and spinal cord hemangioblastomas. Surg Neurol 9:337341, 1978 Rawe SE, Van Gilder JC, Rothman SLG: Radiographic diagnostic evaluation and surgical treatment of multiple cerebellar, brain stem, and spinal cord hemangioblastomas. Surg Neurol 9:337–341, 1978

    • Search Google Scholar
    • Export Citation
  • 40.

    Rengachary SS, & Blount JP: Hemangioblastomas, in Wilkins RH, & Rengachary SS (eds): Neurosurgery, ed 2. New York: McGraw-Hill, 1996, Vol 1, pp 12051219 Rengachary SS, Blount JP: Hemangioblastomas, in Wilkins RH, Rengachary SS (eds): Neurosurgery, ed 2. New York: McGraw-Hill, 1996, Vol 1, pp 1205–1219

    • Search Google Scholar
    • Export Citation
  • 41.

    Richard S, , David P, & Marsot-Dupuch K, et al: Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 23:124, 2000 Richard S, David P, Marsot-Dupuch K, et al: Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 23:1–24, 2000

    • Search Google Scholar
    • Export Citation
  • 42.

    Sanford RA, & Smith RA: Hemangioblastoma of the cervicomedullary junction. Report of three cases. J Neurosurg 64:317321, 1986 Sanford RA, Smith RA: Hemangioblastoma of the cervicomedullary junction. Report of three cases. J Neurosurg 64:317–321, 1986

    • Search Google Scholar
    • Export Citation
  • 43.

    Seizinger BR, , Rouleau GA, & Ozelius LJ, et al: von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268269, 1988 Seizinger BR, Rouleau GA, Ozelius LJ, et al: von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269, 1988

    • Search Google Scholar
    • Export Citation
  • 44.

    Silverberg GD, , Reitz BA, & Ream AK: Hypothermia and cardiac arrest in the treatment of giant aneurysms of the cerebral circulation and hemangioblastoma of the medulla. J Neurosurg 55:337346, 1981 Silverberg GD, Reitz BA, Ream AK: Hypothermia and cardiac arrest in the treatment of giant aneurysms of the cerebral circulation and hemangioblastoma of the medulla. J Neurosurg 55:337–346, 1981

    • Search Google Scholar
    • Export Citation
  • 45.

    Spetzger U, , Bertalanffy H, & Huffmann B, et al: Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 19:147151, 1996 Spetzger U, Bertalanffy H, Huffmann B, et al: Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 19:147–151, 1996

    • Search Google Scholar
    • Export Citation
  • 46.

    Standard SC, , Ahuja A, & Livingston K, et al: Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg Neurol 41:405410, 1994 Standard SC, Ahuja A, Livingston K, et al: Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg Neurol 41:405–410, 1994

    • Search Google Scholar
    • Export Citation
  • 47.

    Tognetti F, , Galassi E, & Servadei F, et al: Haemangioblastomas of the brain stem. Neurochirurgia 29:230234, 1986 Tognetti F, Galassi E, Servadei F, et al: Haemangioblastomas of the brain stem. Neurochirurgia 29:230–234, 1986

    • Search Google Scholar
    • Export Citation
  • 48.

    Tory K, , Brauch H, & Linehan M, et al: Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81:10971101, 1989 Tory K, Brauch H, Linehan M, et al: Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81:1097–1101, 1989

    • Search Google Scholar
    • Export Citation
  • 49.

    von Hippel E: Vorstellung eine patienten mit einer sehr ungewohnlieben netzhant. Ber Ophthalmol Ges 24:269, 1895 (Reference unverified) von Hippel E: Vorstellung eine patienten mit einer sehr ungewohnlieben netzhant. Ber Ophthalmol Ges 24:269, 1895 (Reference unverified)

    • Search Google Scholar
    • Export Citation
  • 50.

    Vortmeyer AO, , Gnarra JR, & Emmert-Buck MR, et al: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540543, 1997 Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540–543, 1997

    • Search Google Scholar
    • Export Citation
  • 51.

    Wanebo JE, , Lonser RR, & Glen GN, et al: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. J Neurosurg 98:8294, 2003.Wanebo JE, Lonser RR, Glen GN, et al: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. J Neurosurg 98:82–94, 2003.

    • Search Google Scholar
    • Export Citation
  • 52.

    Yang H, & Kaelin WG Jr: Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. Cell Growth Differ 12:447455, 2001 Yang H, Kaelin WG Jr: Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. Cell Growth Differ 12:447–455, 2001

    • Search Google Scholar
    • Export Citation
  • 53.

    Yasargil MG: Microneurosurgery: In 4 Volumes. New York: Thieme Stratton, 1996, Vol IVB, pp 386389 Yasargil MG: Microneurosurgery: In 4 Volumes. New York: Thieme Stratton, 1996, Vol IVB, pp 386–389

    • Search Google Scholar
    • Export Citation
  • 54.

    Yasargil MG, , Antic J, & Laciga R, et al: The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surg Neurol 3:1418, 1976 Yasargil MG, Antic J, Laciga R, et al: The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surg Neurol 3:141–8, 1976

    • Search Google Scholar
    • Export Citation
  • 55.

    Zbar B, , Kishida T, & Chen F, et al: Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348357, 1996 Zbar B, Kishida T, Chen F, et al: Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348–357, 1996

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 516 237 24
Full Text Views 253 42 4
PDF Downloads 156 29 6
EPUB Downloads 0 0 0